Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1335
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer ; day:21 ; month:4 ; year:2021 ; pages:1-6
Journal of cancer research and clinical oncology ; (21.4.2021), 1-6
- Urheber
-
Rachner, Tilman D.
Kasimir-Bauer, Sabine
Goebel, Andy
Erdmann, Kati
Hoffmann, Oliver
Rauner, Martina
Hofbauer, Lorenz C.
Kimmig, Rainer
Bittner, Ann-Kathrin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-021-03635-1
- URN
-
urn:nbn:de:101:1-2021060722322220376946
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rachner, Tilman D.
- Kasimir-Bauer, Sabine
- Goebel, Andy
- Erdmann, Kati
- Hoffmann, Oliver
- Rauner, Martina
- Hofbauer, Lorenz C.
- Kimmig, Rainer
- Bittner, Ann-Kathrin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Podocalyxin is a marker of poor prognosis in colorectal cancer
CDCA8 as an independent predictor for a poor prognosis in liver cancer
Small bowel angioectasia as a marker of frailty and poor prognosis
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Podocalyxin is a marker of poor prognosis in colorectal cancer
CDCA8 as an independent predictor for a poor prognosis in liver cancer
Small bowel angioectasia as a marker of frailty and poor prognosis
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Podocalyxin is a marker of poor prognosis in colorectal cancer
CDCA8 as an independent predictor for a poor prognosis in liver cancer
Small bowel angioectasia as a marker of frailty and poor prognosis
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients